1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Data Triangulation
2.3.1 Research Assumptions
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Attractive Opportunities in Coated Paper Market
4.2 Coated Paper Market Growth, By Application
4.3 Coated Paper Market Share, By Region and Type
4.4 Coated Paper Market Attractiveness
5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Coating Material
5.2.2 By Type
5.2.3 By Application
5.2.4 By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Development of Customized Grades According to Applications
5.3.1.2 New Emerging Markets
5.3.2 Restraints
5.3.2.1 Growing Electronic Media Industry
5.3.3 Opportunities
5.3.3.1 Expansion Opportunities in Developing Countries
5.3.4 Challenges
5.3.4.1 Recycling of Coated Paper
6 Industry Trends (Page No. – 40)
6.1 Introduction
6.2 Value Chain Analysis
6.2.1 Raw Material Suppliers
6.2.2 Coated Paper Producers
6.2.3 Applications
6.3 Porter’s Five Forces Analysis
6.4 Bargaining Power of Suppliers
6.5 Threat of New Entrants
6.6 Threat of Substitutes
6.7 Bargaining Power of Buyers
6.8 Intensity of Competitive Rivalry
7 Coated Paper Market, By Coating Material (Page No. – 44)
7.1 Introduction
7.2 Market Size & Forecast
7.3 Grounded Calcium Carbonate
7.4 Precipitated Calcium Carbonate
7.5 Kaolin Clay
7.6 Talc
7.7 Starch
7.8 SB Latex
7.9 Titanium Dioxide
7.10 Wax
7.11 Others
8 Coated Paper Market, By Type (Page No. – 60)
8.1 Introduction
8.2 Revenue Pocket Matrix, By Type
8.3 Standard Coated Fine Paper
8.4 Low Coat Weight Paper
8.5 Art Paper
8.6 Coated Fine Paper
8.7 Coated Groundwood Paper
8.8 Others
9 Coated Paper Market, By Application (Page No. – 72)
9.1 Introduction
9.2 Market Size & Forecast
9.3 Printing
9.4 Packaging
9.5 Business Communication
9.6 Labels
9.7 Others
10 Coated Paper Market, By Region (Page No. – 82)
10.2 Introduction
10.3 Asia-Pacific
10.3.1 China
10.3.2 India
10.3.3 Japan
10.3.4 South Korea
10.3.5 Indonesia
10.3.6 Rest of Asia-Pacific
10.4 North America
10.4.1 U.S.
10.4.2 Canada
10.4.3 Mexico
10.5 Europe
10.6 South America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of South America
10.7 Middle East & Africa
10.7.1 Saudi Arabia
10.7.2 UAE
10.7.3 Rest of Middle East & Africa
11 Competitive Landscape (Page No. – 142)
11.1 Overview
11.2 Expansion: the Most Popular Growth Strategy
11.3 Market Share Analysis
11.3.1 Nippon Paper Industries Leads the Coated Paper Market Globally
11.4 Competitive Situation and Trends
11.4.1 Expansions
11.4.2 New Product Developments
11.4.3 Mergers & Acquisitions
11.4.4 Joint Ventures & Partnerships
12 Company Profiles (Page No. – 149)
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 Oji Holdings Corporation
12.2 Nippon Paper Industries Co., Ltd.
12.3 Stora Enso OYJ
12.4 Sappi Limited
12.5 Asia Pulp & Paper
12.6 Verso Corporation
12.7 UPM
12.8 Resolute Forest Products
12.9 Packaging Corporation of America
12.10 Dunn Paper Company
*Details Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 171)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
TABLE 1 INDICATIVE LIST OF ONGOING CLINICAL TRIALS CONDUCTED ON HUMANIZED MICE MODELS 53
TABLE 2 INDICATIVE LIST OF RESEARCH STUDIES CONDUCTED ON HUMANIZED MICE MODELS (2013–2016) 55
TABLE 3 GLOBAL HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 58
TABLE 4 GENETIC HUMANIZED MOUSE MODEL MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 59
TABLE 5 GLOBAL CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 60
TABLE 6 CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 60
TABLE 7 NORTH AMERICA: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 61
TABLE 8 CD34 HUMANIZED MOUSE MODEL MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 62
TABLE 9 NORTH AMERICA: CD34 HUMANIZED MOUSE MODEL MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 62
TABLE 10 PBMC HUMANIZED MOUSE MODEL MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 63
TABLE 11 NORTH AMERICA: PBMC HUMANIZED MOUSE MODEL MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 63
TABLE 12 RECENT HIV STUDIES USING HUMANIZED MOUSE MODEL 64
TABLE 13 BLT HUMANIZED MOUSE MODEL MARKET SIZE, BY REGION,
2014–2021 (USD THOUSAND) 65
TABLE 14 NORTH AMERICA: BLT HUMANIZED MOUSE MODEL MARKET SIZE, BY COUNTRY, 2014–2021 (USD THOUSAND) 65
TABLE 15 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD MILLION) 67
TABLE 16 INDICATIVE LIST OF RECENT CANCER RESEARCH STUDIES USING HUMANIZED MICE MODELS 68
TABLE 17 HUMANIZED MOUSE MODEL MARKET FOR ONCOLOGY, BY REGION,
2014–2021 (USD MILLION) 69
TABLE 18 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR ONCOLOGY,
BY COUNTRY, 2014–2021 (USD MILLION) 70
TABLE 19 HUMANIZED MOUSE MODEL MARKET SIZE FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 20 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 21 HUMANIZED MOUSE MODEL MARKET SIZE FOR NEUROSCIENCES, BY REGION, 2014-2021 (USD MILLION) 72
TABLE 22 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR NEUROSCIENCES, BY COUNTRY, 2014–2021 (USD MILLION) 73
TABLE 23 HUMANIZED MOUSE MODEL MARKET SIZE FOR TOXICOLOGY, BY REGION,
2014-2021 (USD MILLION) 74
TABLE 24 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR TOXICOLOGY,
BY COUNTRY, 2014–2021 (USD MILLION) 74
TABLE 25 HUMANIZED MOUSE MODEL MARKET SIZE FOR HEMATOPOIESIS, BY REGION, 2014-2021 (USD MILLION) 75
TABLE 26 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR HEMATOPOIESIS, BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 27 HUMANIZED MOUSE MODEL MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION) 76
TABLE 28 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 29 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 80
TABLE 30 HUMANIZED MOUSE MODEL MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 81
TABLE 31 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2014–2021 (USD MILLION) 81
TABLE 32 HUMANIZED MOUSE MODEL MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014–2021 (USD MILLION) 82
TABLE 33 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 83
TABLE 34 HUMANIZED MOUSE MODEL MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2014–2021 (USD MILLION) 84
TABLE 35 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2014–2021 (USD MILLION) 84
TABLE 36 HUMANIZED MOUSE MODEL MARKET, BY REGION, 2014–2021 (USD MILLION) 86
TABLE 37 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET, BY COUNTRY,
2014–2021 (USD MILLION) 89
TABLE 38 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET, BY TYPE,
2014–2021 (USD MILLION) 89
TABLE 39 NORTH AMERICA: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE,
BY TYPE, 2014–2021 (USD MILLION) 89
TABLE 40 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD MILLION) 90
TABLE 41 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 90
TABLE 42 NIH FUNDING FOR PROJECTS RELATED TO ANIMAL MODELS 91
TABLE 43 RECENT EVENTS RELATED TO THE ANIMAL MODEL MARKET 93
TABLE 44 U.S.: HUMANIZED MOUSE MODEL MARKET, BY TYPE, 2014–2021 (USD MILLION) 94
TABLE 45 U.S.: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 95
TABLE 46 U.S.: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD MILLION) 95
TABLE 47 U.S.: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 96
TABLE 48 CANADA: HUMANIZED MOUSE MODEL MARKET, BY TYPE,
2014–2021 (USD MILLION) 97
TABLE 49 CANADA: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD THOUSAND) 97
TABLE 50 CANADA: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD THOUSAND) 98
TABLE 51 CANADA: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 98
TABLE 52 EUROPE: HUMANIZED MOUSE MODEL MARKET, BY TYPE,
2014–2021 (USD MILLION) 103
TABLE 53 EUROPE: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 103
TABLE 54 EUROPE: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD MILLION) 104
TABLE 55 EUROPE: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 104
TABLE 56 ASIA-PACIFIC: HUMANIZED MOUSE MODEL MARKET, BY TYPE,
2014–2021 (USD MILLION) 113
TABLE 57 ASIA-PACIFIC: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE, 2014–2021 (USD THOUSAND) 113
TABLE 58 ASIA-PACIFIC: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD THOUSAND) 114
TABLE 59 ASIA-PACIFIC: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 114
TABLE 60 ROW: HUMANIZED MOUSE MODEL MARKET, BY TYPE, 2014–2021 (USD MILLION) 117
TABLE 61 ROW: CELL-BASED HUMANIZED MOUSE MODEL MARKET SIZE, BY TYPE,
2014–2021 (USD THOUSAND) 117
TABLE 62 ROW: HUMANIZED MOUSE MODEL MARKET, BY APPLICATION,
2014–2021 (USD THOUSAND) 118
TABLE 63 ROW: HUMANIZED MOUSE MODEL MARKET, BY END USER,
2014–2021 (USD MILLION) 118
TABLE 64 AGREEMENTS, COLLABORATIONS, CONTRACTS, ALLIANCES, AND PARTNERSHIPS, 2013–2016 125
TABLE 65 GRANT/FUND, 2013–2016 126
TABLE 66 PRODUCT LAUNCHES, 2013–2016 127
TABLE 67 EXPANSIONS, 2013–2016 128
TABLE 68 ACQUISITIONS, 2013–2016 129
TABLE 69 OTHER STRATEGIES, 2013–2016 131
LIST OF FIGURES
FIGURE 1 GLOBAL HUMANIZED MOUSE MODEL MARKET: RESEARCH METHODOLOGY 20
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 26
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 6 RESEARCH DESIGN 28
FIGURE 7 DATA TRIANGULATION METHODOLOGY 29
FIGURE 8 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY APPLICATION (2016) 31
FIGURE 9 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY TYPE 32
FIGURE 10 GLOBAL CELL-BASED HUMANIZED MOUSE MODEL MARKET, BY TYPE 33
FIGURE 11 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY END USER 34
FIGURE 12 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 35
FIGURE 13 INCREASING R&D ACTIVITIES, INVESTMENTS, AND GRANTS TO DRIVE GROWTH IN THE GLOBAL HUMANIZED MOUSE MODEL MARKET 36
FIGURE 14 NORTH AMERICA TO DOMINATE THE GLOBAL HUMANIZED MOUSE MODEL MARKET IN 2016 37
FIGURE 15 ONCOLOGY TO FORM THE LARGEST APPLICATION SEGMENT IN THE GLOBAL HUMANIZED MOUSE MODEL MARKET 38
FIGURE 16 ASIA-PACIFIC TO REGISTER THE HIGHEST MARKET GROWTH FROM 2016 TO 2021 38
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 18 U.S.: CLINICAL TRIALS USING HUMANIZED MICE MODELS,
BY INDICATION (2013–2023) 50
FIGURE 19 U.S.: CLINICAL TRIALS USING HUMANIZED MICE MODELS, BY COMPLETION 51
FIGURE 20 U.S.: CLINICAL TRIALS USING HUMANIZED MICE MODELS, BY PHASE (2013–2023) 52
FIGURE 21 U.S.: RESEARCH STUDIES USING HUMANIZED MICE MODELS,
BY INDICATION (2012–2016) 54
FIGURE 22 GENETIC HUMANIZED MOUSE MODEL TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016 57
FIGURE 23 CD34 HUMANIZED MOUSE MODEL TO GROW AT THE HIGHEST CAGR BETWEEN 2016 AND 2021 59
FIGURE 24 ONCOLOGY SEGMENT TO DOMINATE THE HUMANIZED MOUSE
MODEL MARKET IN 2016 67
FIGURE 25 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE HUMANIZED MOUSE MODEL MARKET IN 2016 79
FIGURE 26 NORTH AMERICA DOMINATES THE MARKET FOR HUMANIZED MOUSE MODELS 87
FIGURE 27 NORTH AMERICA: HUMANIZED MOUSE MODEL MARKET SNAPSHOT 88
FIGURE 28 EUROPE: HUMANIZED MOUSE MODEL MARKET SNAPSHOT 99
FIGURE 29 INCREASE IN CELL THERAPY PRECLINICAL STUDIES IN THE U.K., 2013-2016 101
FIGURE 30 ASIA-PACIFIC: HUMANIZED MOUSE MODEL MARKET SNAPSHOT 105
FIGURE 31 REST OF THE WORLD: HUMANIZED MOUSE MODEL MARKET SNAPSHOT 115
FIGURE 32 KEY DEVELOPMENTS IN THE HUMANIZED MOUSE MODEL MARKET, 2013–2016 119
FIGURE 33 MARKET SHARE ANALYSIS FOR CELL-BASED HUMANIZED MOUSE MODEL,
BY KEY PLAYER, 2015 120
FIGURE 34 MARKET SHARE ANALYSIS FOR GENETIC HUMANIZED MOUSE MODEL,
BY KEY PLAYER, 2015 122
FIGURE 35 AGREEMENTS, COLLABORATIONS, CONTRACTS, ALLIANCES, AND PARTNERSHIPS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 123
FIGURE 36 AGREEMENTS, COLLABORATIONS, ALLIANCES, CONTRACTS, AND PARTNERSHIPS, BY COMPANY (2013–2016) 124
FIGURE 37 GRANT/FUND, BY COMPANY (2013–2016) 126
FIGURE 38 PRODUCT LAUNCHES, BY COMPANY (2013–2016) 127
FIGURE 39 EXPANSIONS, BY COMPANY (2013–2016) 128
FIGURE 40 ACQUISITIONS, BY COMPANY (2013–2016) 129
FIGURE 41 OTHER STRATEGIES, BY COMPANY (2013–2016) 130
FIGURE 42 PRODUCT MIX OF THE TOP 3 PLAYERS IN THE HUMANIZED MOUSE MODELS MARKET 132
FIGURE 43 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2015) 133
FIGURE 44 HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT (2015) 141
FIGURE 45 GENOWAY S.A.: COMPANY SNAPSHOT (2015) 145
FIGURE 46 TRANS GENIC, INC.: COMPANY SNAPSHOT (2015) 153
FIGURE 47 CHAMPIONS ONCOLOGY, INC.: COMPANY SNAPSHOT (2015) 156
【レポートのキーワード】
ヒト化マウスモデル、ヒト化マウスモデル種類、遺伝子、細胞ベース、CD34、PBMC、BLT、ヒト化マウスモデル用途、需要先
